Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111, in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry

H Nabi, B Glintborg, A G Loft, O Hendricks, J K Pedersen, S A Just, R Ahmed, K Danebod, H L Munk, A Colic, A Linauskas, D V Jensen, L B Christensen, N Manilo, N Lomborg, S Kristensen, F Mehnert, N S Krogh, M L Hetland

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalScandinavian Journal of Rheumatology
Volume50
Issue numberSuppl. 130
Pages (from-to)14-15
Number of pages2
ISSN0300-9742
Publication statusPublished - Aug 2021
Event38th Scandinavian Congress of Rheumatology - Scandic Parken, Ålesund, Norway
Duration: 1 Sep 20214 Sep 2021
Conference number: 38

Conference

Conference38th Scandinavian Congress of Rheumatology
Number38
LocationScandic Parken
Country/TerritoryNorway
CityÅlesund
Period01/09/202104/09/2021

Cite this